Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
None listed
Sponsors
YourZooki holdings Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender 18 to 70 years (inclusive) Subjects giving written informed consent /assent form Patients having presence of iron deficiency anemia below normal or low hemoglobin as per lab reports. Non-use of any iron supplement for 2 weeks prior to enrolment to the study and to know the dosage timing of Calcium supplement if any. Willing to come for regular follow-up visits. In the opinion of the investigator, able to comply with the requirements of the protocol.
Exclusion criteria
Exclusion criteria: Patients with serious cardiovascular, cerebro-vascular respiratory liver or renal disease or any other disorder. Known history of hypersensitivity to herbal extracts or dietary supplements. Known or suspected hypersensitivity to iron or any of the components of Investigational Product. Pregnant women, lactating women and women of child bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy. Medical history of current hematological disorders other than iron deficiency anemia (e.g. aplastic anemia, megaloblastic anemia, sideroblastic anemia, pernicious anemia, thalassemia, sickle cell anemia, etc.). Evidence of alcohol or drug abuse, that may, in the opinion of the Investigator interferes with study compliance or prevents understanding of the objectives, investigational procedures or possible consequences of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hematological parameters CBC RBC indices from baseline to Day 15 Day 30Timepoint: Day 15 Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in quality of life (QoL assessed by SF-36) from baseline to Day 15 Day 30Timepoint: Day 15 Day 30 | — |
Countries
India
Contacts
Public ContactShalini Dayananda
Unitree Health Care Diagnostics
Outcome results
None listed